Cargando…

Neutrophil-To-Lymphocyte Ratio Predicted Long-Term Chemotherapy Benefits In Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer Patients Without Sensitive Mutations

PURPOSE: To investigate the predictive capability of clinical parameters for long-term chemotherapy benefits among stage IIIB-IV non-squamous non-small cell lung cancer (NSCLC) patients without sensitive mutations. PATIENTS AND METHODS: We investigated the clinical features of 206 stage IIIB-IV non-...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xing, Zeng, Wei-Hua, Zhou, Yu-Qi, Ji, Yan-Ying, Li, Wei-Zhan, Zhang, Li-Yi, Guo, Yue-Fei, Feng, Ding-Yun, Zhang, Tian-Tuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815757/
https://www.ncbi.nlm.nih.gov/pubmed/31695433
http://dx.doi.org/10.2147/OTT.S225544